| Metric | შპს ნეოფარმი + | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾16.3m₾13.9m | ₾2.36bn₾2.11bn |
| Revenue growth | 17.4% | 11.8% |
| Profitability | ||
| EBITDA | -₾836k-₾1.3m | — |
| EBITDA margin | -5.1%-9.0% | — |
| Net profit | -₾873k-₾1.3m | ₾1.24bn₾1.12bn |
| Net margin | -5.4%-9.1% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾5.7m₾6.3m | ₾37.66bn₾31.77bn |
| Total equity | ₾14k₾887k | ₾5.45bn₾4.75bn |
| ROE | -6150.6%-142.2% | 22.8%23.6% |